Jackevicius C - Search Results

1

Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention.

Blackman DJ, Pinto R, Ross JR, Seidelin PH, Ing D, Jackevicius C, Mackie K, Chan C, Dzavik V. Blackman DJ, et al. Among authors: jackevicius c. Am Heart J. 2006 Jan;151(1):146-52. doi: 10.1016/j.ahj.2005.03.018. Am Heart J. 2006. PMID: 16368308

2

Acute profound thrombocytopenia associated with eptifibatide therapy.

Nagge J, Jackevicius C, Dzavik V, Ross JR, Seidelin P. Nagge J, et al. Among authors: jackevicius c. Pharmacotherapy. 2003 Mar;23(3):374-9. doi: 10.1592/phco.23.3.374.32107. Pharmacotherapy. 2003. PMID: 12627937

3

Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery.

Cheng DK, Jackevicius CA, Seidelin P, Feindel C, Rouleau JL. Cheng DK, et al. Among authors: jackevicius ca. Can J Cardiol. 2004 Feb;20(2):223-8. Can J Cardiol. 2004. PMID: 15010747 Review.

4

Anti-Xa monitoring of enoxaparin for acute coronary syndromes in patients with renal disease.

Ma JM, Jackevicius CA, Yeo E. Ma JM, et al. Ann Pharmacother. 2004 Oct;38(10):1576-81. doi: 10.1345/aph.1E096. Epub 2004 Aug 24. Ann Pharmacother. 2004. PMID: 15328396

5

Routine use of glycoprotein IIb/IIIa inhibitor therapy is associated with an improved in-hospital outcome after percutaneous coronary intervention: Insights from a large, prospective, single-centre registry.

Jackevicius CA, Pinto R, Daly P, Mackie K, Dzavik V. Jackevicius CA, et al. Can J Cardiol. 2005 Jan;21(1):27-32. Can J Cardiol. 2005. PMID: 15685299

6

The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention.

Ma JM, Jackevicius CA, Genus U, Dzavik V. Ma JM, et al. Can J Cardiol. 2006 Apr;22(5):419-23. doi: 10.1016/s0828-282x(06)70928-x. Can J Cardiol. 2006. PMID: 16639478 Free PMC article.

7

Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years.

Ko DT, Yun L, Wijeysundera HC, Jackevicius CA, Rao SV, Austin PC, Marquis JF, Tu JV. Ko DT, et al. Among authors: jackevicius ca. Circ Cardiovasc Interv. 2010 Apr;3(2):140-7. doi: 10.1161/CIRCINTERVENTIONS.109.928721. Epub 2010 Mar 23. Circ Cardiovasc Interv. 2010. PMID: 20332382

8

Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada.

Lu L, Krumholz HM, Tu JV, Ross JS, Ko DT, Jackevicius CA. Lu L, et al. Am Heart J. 2014 May;167(5):683-9. doi: 10.1016/j.ahj.2014.01.014. Epub 2014 Feb 26. Am Heart J. 2014. PMID: 24766978 Free PMC article. Clinical Trial.

9

Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome.

Jackevicius CA, Tu JV, Krumholz HM, Austin PC, Ross JS, Stukel TA, Koh M, Chong A, Ko DT. Jackevicius CA, et al. J Am Heart Assoc. 2016 Apr 19;5(4):e003350. doi: 10.1161/JAHA.116.003350. J Am Heart Assoc. 2016. PMID: 27098970 Free PMC article.

10

Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial.

Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Khan NF, Lee M, Vachon A, Iliadis TL, Hollands W, Doheny S, Elman S, Kraft JM, Naseem S, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD. Choudhry NK, et al. Among authors: jackevicius ca. Am Heart J. 2016 Oct;180:90-7. doi: 10.1016/j.ahj.2016.07.017. Epub 2016 Aug 8. Am Heart J. 2016. PMID: 27659887 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters